Literature DB >> 16288760

Impact of oxidized low density lipoprotein on vascular cells.

Jan Galle1, Thomas Hansen-Hagge, Christoph Wanner, Stefan Seibold.   

Abstract

Oxidized LDL (OxLDL) is a proatherogenic lipoprotein, accumulating in the vascular wall and contributing to the pathogenesis of vascular dysfunction early in the development of atherosclerosis. Enhanced serum levels of OxLDL, as well as antibodies against its epitopes, are predictive for endothelial dysfunction and coronary heart disease. While enhanced oxidative stress is one factor triggering formation of OxLDL, OxLDL itself has been identified as a potent stimulus for vascular oxygen radical formation, causing a vicious circle. OxLDL-induced O(2)(-) formation, largely through activation of NADPH oxidase, but also through uncoupling of endothelial NO-synthase and through direct O(2)(-) release, leads to endothelial dysfunction. Furthermore, OxLDL-induced O(2)(-) formation has a strong impact on tissue remodeling, resulting in either cell growth - proliferation or hyperplasia - or apoptotic cell death. The effect of OxLDL on cell cycle regulation is mediated by activation of the small GTPase RhoA and consequent regulation of p27(KIP1), a key enzyme of the cell cycle. In addition, OxLDL-induced activation of RhoA sensitizes the contractile apparatus of the vessel wall, enhancing the contractile tonus and favoring vasospasm. Thus, through a variety of mechanisms, OxLDL importantly contributes to vascular dysfunction and remodeling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288760     DOI: 10.1016/j.atherosclerosis.2005.10.005

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  56 in total

1.  Effect of oxidized low-density lipoprotein concentration polarization on human smooth muscle cells' proliferation, cycle, apoptosis and oxidized low-density lipoprotein uptake.

Authors:  Zufeng Ding; Shijie Liu; Bo Yang; Yubo Fan; Xiaoyan Deng
Journal:  J R Soc Interface       Date:  2011-11-02       Impact factor: 4.118

2.  Profound influence of LDL oxidative status and monocyte co-cultures on baboon endothelial activation.

Authors:  Juan Xiao; Vida Hondara; Xing Li Wang; John L Vandeberg; Qiang Shi
Journal:  Am J Cardiovasc Dis       Date:  2011-12-15

3.  Implication of lipoprotein associated phospholipase A2 activity in oxLDL uptake by macrophages.

Authors:  Konstantinos P Markakis; Maria K Koropouli; Stavroula Grammenou-Savvoglou; Ewoud C van Winden; Andromaxi A Dimitriou; Constantinos A Demopoulos; Alexandros D Tselepis; Eleni E Kotsifaki
Journal:  J Lipid Res       Date:  2010-03-23       Impact factor: 5.922

Review 4.  Candidate biomarkers for the detection of coronary plaque destabilization and rupture.

Authors:  Anand Prasad; Sotirios Tsimikas
Journal:  Curr Atheroscler Rep       Date:  2008-08       Impact factor: 5.113

5.  Regulation of Coronary Endothelial Function by Interactions between TNF-α, LOX-1 and Adiponectin in Apolipoprotein E Knockout Mice.

Authors:  Xiuping Chen; Hanrui Zhang; Michael A Hill; Cuihua Zhang; Yoonjung Park
Journal:  J Vasc Res       Date:  2016-04-07       Impact factor: 1.934

6.  Endothelial long non-coding RNAs regulated by oxidized LDL.

Authors:  Krishna K Singh; Pratiek N Matkar; Yi Pan; Adrian Quan; Vijay Gupta; Hwee Teoh; Mohammed Al-Omran; Subodh Verma
Journal:  Mol Cell Biochem       Date:  2017-03-18       Impact factor: 3.396

7.  Endothelial dysfunction in patients with primary aldosteronism: a biomarker of target organ damage.

Authors:  G Liu; G-S Yin; J-y Tang; D-J Ma; J Ru; X-H Huang
Journal:  J Hum Hypertens       Date:  2014-02-20       Impact factor: 3.012

8.  Effect of bariatric surgery on microvascular dysfunction associated to metabolic syndrome: a 12-month prospective study.

Authors:  J F Martín-Rodríguez; A Cervera-Barajas; A Madrazo-Atutxa; P P García-Luna; J L Pereira; J Castro-Luque; A León-Justel; S Morales-Conde; J R Castillo; A Leal-Cerro; D A Cano
Journal:  Int J Obes (Lond)       Date:  2014-01-28       Impact factor: 5.095

Review 9.  Antiphospholipid antibodies and atherosclerosis: insights from systemic lupus erythematosus and primary antiphospholipid syndrome.

Authors:  Paul R J Ames; Annamaria Margarita; Jose Delgado Alves
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

10.  Oxidized low-density lipoprotein and ankle-brachial pressure index in patients with clinically evident peripheral arterial disease.

Authors:  Ruben Miguel Ayzin Rosoky; Nelson Wolosker; Michel Nasser; Antonio Eduardo Zerati; Magnus Gidlund; Pedro Puech-Leão
Journal:  Clinics (Sao Paulo)       Date:  2010-04       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.